NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News Archive

You are here: Home > News > News for COVID-19

COVID-19 News

Study confirms longer-term lung damage after COVID-19

25 May 2021 · Listed under COVID-19, Imaging, Respiratory Medicine

A study by Oxford and Sheffield researchers using a cutting-edge method of imaging has identified persistent damage to the lungs of COVID-19 patients at least three months after they were discharged from hospital, and for some patients even longer. This damage was not detected by routine CT ... READ MORE

Trial finds no benefit from using colchicine in hospitalised COVID-19 patients

19 May 2021 · Listed under COVID-19, Translational Data Science

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found no evidence that that the drug colchicine has any meaningful clinical benefits for patients hospitalised with COVID-19. Colchicine is used to treat inflammation and pain in ... READ MORE

Messaging focused on personal rather than collective benefits more effective for COVID-19 vaccination

13 May 2021 · Listed under COVID-19, Life-saving Vaccines

The largest ever study of COVID-19 vaccine messaging shows that emphasising the personal benefits of vaccination may be the most effective way to persuade people who are sceptical about the jab. For the one in ten who say they won't take a COVID-19 vaccine, messaging that focuses on personal ... READ MORE

Oxford BRC researchers named among new Academy of Medical Sciences fellows

12 May 2021 · Listed under COVID-19, Inflammation across Tissues, Life-saving Vaccines, Preventive Neurology, Translational Data Science

A number of leading researchers supported by the NIHR Oxford Biomedical Research Centre are among 50 prominent biomedical and health scientists elected to the Academy of Medical Sciences’ respected and influential Fellowship. The new Fellows include Oxford BRC experts who have spearheaded the ... READ MORE

Data reveals COVID-19 risk factors for people with type 1 diabetes

11 May 2021 · Listed under COVID-19, Metabolic Experimental Medicine, Translational Data Science

The largest study of people with type 1 diabetes admitted to hospital with COVID-19 has found that those with higher body mass index (BMI), poorer kidney function and the presence of microvascular complications were at greater risk of death and/or admission to intensive care. However, the ... READ MORE

Study highlights role of BMI in increased COVID-19 risks

29 April 2021 · Listed under COVID-19, Obesity, Diet and Lifestyle, Translational Data Science

A study by University of Oxford researchers has found that the risk of admission to hospital, admission to ICU or death from COVID-19 increases progressively above a ‘normal’ BMI of 23, even without other comorbidities. The research team, who are supported by the NIHR Oxford Biomedical Research ... READ MORE

Azithromycin not effective against COVID-19, trial confirms

26 April 2021 · Listed under COVID-19, Respiratory Medicine

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19. The ATOMIC2 trial, which was supported by the NIHR Oxford Biomedical Research Centre (BRC), was established to investigate if a common ... READ MORE

National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines

23 April 2021 · Listed under COVID-19, Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics, Translational Data Science

Data from the national COVID-19 Infection Survey, which is led by senior NIHR Oxford BRC researcher Professor Sarah Walker, has revealed the impact of vaccination on antibody responses and new infections in a large group of adults from the general population. This major community surveillance ... READ MORE

Human challenge trial launches to study immune response to COVID-19

19 April 2021 · Listed under COVID-19, Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics

Researchers at the University of Oxford have launched a human challenge trial to look at what kind of immune response can stop people from becoming re-infected. The team, led by the NIHR Oxford Biomedical Research Centre Director Professor Helen McShane (pictured right), also want to find out ... READ MORE

National study looks at long-term lung damage from COVID-19

7 April 2021 · Listed under COVID-19, Respiratory Medicine

A new national study involving researchers from Oxford will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent ... READ MORE

Risk of severe COVID-19 from asthma and other respiratory diseases may be only modestly increased, new analysis suggests

1 April 2021 · Listed under COVID-19, Obesity, Diet and Lifestyle, Respiratory Medicine, Translational Data Science

An analysis of 8.3 million health care records in England shows that people with asthma have only a small increased risk of developing severe Covid-19. The study, led by University of Oxford researchers, examined routine patient data collected between January and April 2020 to generate risk ... READ MORE

Oxford researchers release cheap, quick COVID-19 antibody test

29 March 2021 · Listed under COVID-19, Inflammation across Tissues

An international research team led by Oxford University scientists has developed a portable test for antibodies that fight the novel coronavirus that causes COVID-19. The test, which spots the presence of virus-fighting antibodies rather than a coronavirus infection, can be adapted to work on ... READ MORE

New study finds strong immune response following COVID-19 vaccination

26 March 2021 · Listed under COVID-19, Inflammation across Tissues, Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics

A new study has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine, and that after two doses levels of protection were even stronger. The PITCH (Protective Immunity from T cells to COVID-19 in Health workers) study, led by ... READ MORE

Seven in ten patients hospitalised with COVID-19 not fully recovered five months after discharge

24 March 2021 · Listed under Cardiovascular Medicine, COVID-19, Imaging, Respiratory Medicine

A majority of survivors who left hospital following COVID-19 had not fully recovered five months after discharge and continued to experience negative impacts on their physical and mental health, as well as their ability to work, according to results released by a major national study into the ... READ MORE

Two doses of vaccine offer same protection from COVID as prior infection, study finds

15 March 2021 · Listed under COVID-19, Life-saving Vaccines, Modernising Medical Microbiology and Big Infection Diagnostics, Translational Data Science

Two doses of either the Pfizer or Oxford-AstraZeneca vaccine offer similar protection against symptomatic SARS-CoV-2 infection to that coming from natural immunity after infection, an ongoing study of healthcare workers has found. None of the 1,456 healthcare workers at Oxford University ... READ MORE

Oxford study reveals public attitudes to vaccine roll-out programmes

23 February 2021 · Listed under COVID-19, Life-saving Vaccines

An international study led by University of Oxford health economists and political scientists has found that there is much greater consistency in public attitudes across a number of countries about who should be prioritised for COVID-19 vaccination than there is in national policies. The study, ... READ MORE

Oxford study shows high level of readmissions and death after COVID-19 discharge

22 February 2021 · Listed under COVID-19, Translational Data Science

Some 30% of patients discharged after being admitted to hospital with community-acquired COVID-19 had been readmitted or died within 60 days, a study by Oxford researchers has shown. In a paper published in the European Journal of Public Health, they found that, as anticipated, rates of ... READ MORE

Oxford-led technology to help those at high risk from Covid-19

16 February 2021 · Listed under COVID-19, Multimorbidity and Long-Term Conditions, Translational Data Science

More people in England at high risk from Covid-19 will get priority access to vaccines thanks to new technology developed by a University of Oxford-led team of researchers that can identify those who may be most vulnerable to the virus. Research led by Professor Julia Hippisley-Cox in the ... READ MORE

Oxford University extends COVID-19 vaccine study to children

15 February 2021 · Listed under COVID-19, Life-saving Vaccines

The University of Oxford coronavirus vaccine team has launched the first study to assess the safety and immune responses in children and young adults of their ChAdOx1 nCoV-19 vaccine. The study, which will be conducted with partner sites in London, Southampton and Bristol, builds on previous ... READ MORE

Tocilizumab found to reduce deaths in hospitalised COVID-19patients

11 February 2021 · Listed under COVID-19, Translational Data Science

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found that the anti-inflammatory drug, tocilizumab, reduces the risk of death when given to hospitalised patients with severe COVID-19. The trial, which received core funding from the NIHR Oxford ... READ MORE

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »

Other News

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre